Rescue therapy with alemtuzumab in multiple sclerosis post-natalizumab puerperium reactivation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Clinical Neurology,Dermatology,General Medicine
Link
http://link.springer.com/article/10.1007/s10072-017-3135-y/fulltext.html
Reference6 articles.
1. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N Engl J Med 339(5):285–291
2. Vukusic S, Ionescu I, El-Etr M, Schumacher M, Baulieu EE, Cornu C et al (2004) Pregnancy in multiple sclerosis group. Brain 127(Pt 6):1353–1360
3. Théaudin M, Elefant E, Senat MV (2015) Natalizumab continuation during pregnancy in a patient with previous severe IRIS syndrome. J Neurol Sci 359(1–2):211–212
4. Friend S, Richman S, Bloomgren G, Cristiano LM, Wenten M (2016) Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study. BMC Neurol. 16(1):150
5. Berger JR, Fox RJ (2016) Reassessing the risk of natalizumab-associated PML. J Neurovirol 22(4):533–535
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis;Therapeutic Advances in Neurological Disorders;2023-01
2. Inflammasome Proteins As Biomarkers of Multiple Sclerosis;Frontiers in Neurology;2018-03-19
3. News on the journal Neurological Sciences in 2017;Neurological Sciences;2018-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3